Stock Quality:
Last 7 days
-30.2%
Last 30 days
448.9%
Last 90 days
525.2%
Trailing 12 Months
453.1%
TLRY RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 826.7M | 821.3M | 830.8M | 0 |
| 2024 | 743.2M | 788.9M | 812.0M | 829.2M |
| 2023 | 596.3M | 627.1M | 650.9M | 700.5M |
| 2022 | 617.3M | 628.4M | 613.6M | 602.5M |
| 2021 | 361.3M | 370.7M | 482.2M | 513.4M |
| 2020 | 295.7M | 320.3M | 333.5M | 348.8M |
| 2019 | 58.4M | 179.3M | 293.7M | 281.1M |
| 2018 | 23.3M | 28.1M | 32.7M | 43.1M |
| 2017 | 14.6M | 16.6M | 18.6M | 20.5M |
| 2016 | 0 | 0 | 0 | 12.6M |
| CEO | Mr. Irwin David Simon |
|---|---|
| WEBSITE | tilray.com |
| SECTOR | Healthcare |
| INDUSTRY | Drug Manufacturers Specialty & Generic |
| EMPLOYEES | 1600 |